INS and diabetes mellitus: These data, although produced in an in vitro model, could support data obtained in diabetic patients; therefore, our data could contribute to the indication of a new specific treatment that can improve the insulin sensitivity of pancreatic α-cells and control glucagon levels in patients with diabetes mellitus.